Anabolic steroid-induced hypogonadism: Diagnosis and treatment

Fertility and Sterility

Volumn 101, Issue 5, 2014, Pages 1271-1279

  Rahnema, Cyrus D ^a   Lipshultz, Larry I ^b   Crosnoe, Lindsey E ^a   Kovac, Jason R ^b   Kim, Edward D ^a  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Anabolic androgenic steroids; androgens; clomiphene citrate; erectile dysfunction; gynecomastia; human chorionic gonadotropin; hypogonadotropic hypogonadism; tamoxifen; testicular atrophy

Indexed keywords

ANABOLIC AGENT; ANABOLIC ANDROGENIC STEROID; ANASTROZOLE; ANDROGEN; CHORIONIC GONADOTROPIN; CLOMIFENE; GONADORELIN; GONADOTROPIN; METANDIENONE; NANDROLONE; PERFORMANCE ENHANCING SUBSTANCE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TESTOSTERONE; UNCLASSIFIED DRUG;

ALOPECIA; ANABOLIC STEROID ASSOCIATED HYPOGONADISM; ANDROGEN BLOOD LEVEL; ANDROGEN THERAPY; ARTICLE; AZOOSPERMIA; CORONARY RISK; DEPRESSION; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; ERYTHROCYTOSIS; FATIGUE; FLUID RETENTION; GONADORELIN RELEASE; GONADOTROPIN BLOOD LEVEL; GYNECOMASTIA; HUMAN; HYPERANDROGENISM; HYPERTENSION; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; LIBIDO DISORDER; MALE FERTILITY; MALE INFERTILITY; MEDICAL HISTORY; OLIGOSPERMIA; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POLYCYTHEMIA; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TESTIS ATROPHY; TESTOSTERONE BLOOD LEVEL; CHEMICALLY INDUCED; CONVALESCENCE; MALE; META ANALYSIS; TREATMENT OUTCOME;

ANABOLIC AGENTS; HUMANS; HYPOGONADISM; MALE; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 84899953349     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.02.002     Document Type: Article

References (109)

1. M. Borell Organotherapy and the emergence of reproductive endocrinology J Hist Biol 18 1985 1 30
2. C.E. Brown-Séquard On a new therapeutic method consisting in the use of organic liquids extracted from glands and other organs Br Med J 1 1893 1145 1147
3. C.E. Brown-Séquard The effects produced on man by subcutaneous injection of a liquid obtained from the testicles of animals Lancet 137 1889 105 107
4. G.L. Foss, and S.L. Simpson Oral methyltestosterone and jaundice Br Med J 1 1959 259 263
5. G.L. Foss Some experiences with a new anabolic steroid (methandrostenolone) Br Med J 1 1960 1300 1305
6. J.L. Moss, L.E. Crosnoe, and E.D. Kim Effect of rejuvenation hormones on spermatogenesis Fertil Steril 99 2013 1814 1820
7. F. Hartgens, and H. Kuipers Effects of androgenic-anabolic steroids in athletes Sports Med 34 2004 513 554
8. A.T. Kicman Pharmacology of anabolic steroids Br J Pharmacol 154 2008 502 521
9. A.B. Parkinson, and N.A. Evans Anabolic androgenic steroids: a survey of 500 users Med Sci Sports Exerc 38 2006 644 651
10. N.T. Shahidi A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids Clin Ther 23 2001 1355 1390
11. M.J. Casavant, K. Blake, J. Griffith, A. Yates, and L.M. Copley Consequences of use of anabolic androgenic steroids Pediatr Clin North Am 54 2007 677 690 x
12. C.M. Fronczak, E.D. Kim, and A.B. Barqawi The insults of illicit drug use on male fertility J Androl 33 2012 515 528
13. N. Gårevik, E. Strahm, M. Garle, J. Lundmark, L. Ståhle, and L. Ekström et al. Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids J Steroid Biochem Mol Biol 127 2011 295 300
14. G. Kanayama, J.I. Hudson, and H.G. Pope Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend 98 2008 1 12
15. J.P. Jarow, and L.I. Lipshultz Anabolic steroid-induced hypogonadotropic hypogonadism Am J Sports Med 18 1990 429 431
16. R.M. Coward, S. Rajanahally, J.R. Kovac, R.P. Smith, A.W. Pastuszak, and L.I. Lipshultz Anabolic steroid-induced hypogonadism in young men J Urol 190 2013 2200 2205
17. J. Cohen, R. Collins, J. Darkes, and D. Gwartney A league of their own: demographics, motivations and patterns of use of 1,955 male adult nonmedical anabolic steroid users in the United States J Int Soc Sports Nutr 4 2007 12
18. J.A. Bauermeister, M.A. Zimmerman, M.M. Johns, P. Glowacki, S. Stoddard, and E. Volz Innovative recruitment using online networks: lessons learned from an online study of alcohol and other drug use utilizing a web-based, respondent-driven sampling (webRDS) strategy J Stud Alcohol Drugs 73 2012 834 838
19. N.A. Evans Gym and tonic: a profile of 100 male steroid users Br J Sports Med 31 1997 54 58
20. T. Hildebrandt, J. Langenbucher, S. Carr, P. Sanjuan, and S. Park Predicting intentions for long-term anabolic-androgenic steroid use among men: a covariance structure model Psychol Addict Behav 20 2006 234 240
21. E.J. Ip, M.J. Barnett, M.J. Tenerowicz, and P.J. Perry The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training Pharmacotherapy 31 2011 757 766
22. S.E. McCabe Comparison of web and mail surveys in collecting illicit drug use data: a randomized experiment J Drug Educ 34 2004 61 72
23. S.E. McCabe, C.J. Boyd, A. Young, S. Crawford, and D. Pope Mode effects for collecting alcohol and tobacco data among 3rd and 4th grade students: a randomized pilot study of Web-form versus paper-form surveys Addict Behav 30 2005 663 671
24. P.G. Miller, and A.L. Sønderlund Using the Internet to research hidden populations of illicit drug users: a review Addiction 105 2010 1557 1567
25. H.M. Perry, D. Wright, and B.N. Littlepage Dying to be big: a review of anabolic steroid use Br J Sports Med 26 1992 259 261
26. A. Young, S.E. McCabe, J.A. Cranford, P. Ross-Durow, and C.J. Boyd Nonmedical use of prescription opioids among adolescents: subtypes based on motivation for use J Addict Dis 31 2012 332 341
27. W.W. Franke, and B. Berendonk Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government Clin Chem 43 1997 1262 1279
28. F. Sjöqvist, M. Garle, and A. Rane Use of doping agents, particularly anabolic steroids, in sports and society Lancet 371 2008 1872 1882
29. G.L. de Souza, and J. Hallak Anabolic steroids and male infertility: a comprehensive review BJU Int 108 2011 1860 1865
30. L.D. Johnston, P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg Monitoring the Future national survey results on drug use. Vol. I: Secondary school students 2013 Institute of Social Research, University of Michigan Ann Arbor
31. G. Kanayama, K.J. Brower, R.I. Wood, J.I. Hudson, and H.G. Pope Jr. Anabolic-androgenic steroid dependence: an emerging disorder Addiction 104 2009 1966 1978
32. P.J. Perry, B.C. Lund, M.J. Deninger, E.C. Kutscher, and J. Schneider Anabolic steroid use in weightlifters and bodybuilders: an internet survey of drug utilization Clin J Sport Med 15 2005 326 330
33. I. Pirola, C. Cappelli, A. Delbarba, T. Scalvini, B. Agosti, and D. Assanelli et al. Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism Fertil Steril 94 2010 2331.e1 2331.e3
34. E.R. Cooper, K.C.Y. McGrath, and A.K. Heather In vitro androgen bioassays as a detection method for designer androgens Sensors 13 2013 2148 2163
35. F.G. Cordaro, S. Lombardo, and M. Cosentino Selling androgenic anabolic steroids by the pound: identification and analysis of popular websites on the Internet Scand J Med Sci Sports 21 2011 e247 e259
36. N. Baume, N. Mahler, M. Kamber, P. Mangin, and M. Saugy Research of stimulants and anabolic steroids in dietary supplements Scand J Med Sci Sports 16 2006 41 48
37. A. Cavalcanti Gd, F.D. Leal, B.C. Garrido, M.C. Padilha, and F.R. de Aquino Neto Detection of designer steroid methylstenbolone in "nutritional supplement" using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites Steroids 78 2013 228 233
38. H. Geyer, M.K. Parr, K. Koehler, U. Mareck, W. Schänzer, and M. Thevis Nutritional supplements cross-contaminated and faked with doping substances J Mass Spectrom 43 2008 892 902
39. H. Geyer, M.K. Parr, U. Mareck, U. Reinhart, Y. Schrader, and W. Schänzer Analysis of nonhormonal nutritional supplements for anabolic-androgenic steroids - results of an international study Int J Sports Med 25 2004 124 129
40. M.K. Parr, H. Geyer, B. Hoffmann, K. Köhler, U. Mareck, and W. Schänzer High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market Biomed Chromatogr 21 2007 164 168
41. A.L. Vilella, C. Limsuwat, D.R. Williams, and C.F. Seifert Cholestatic jaundice as a result of combination designer supplement ingestion Ann Pharmacother 47 2013 e33
42. P.A. Cohen Assessing supplement safety - the FDA's controversial proposal N Engl J Med 366 2012 389 391
43. H.G. Pope, G. Kanayama, M. Ionescu-Pioggia, and J.I. Hudson Anabolic steroid users' attitudes toward physicians Addiction 99 2004 1189 1194
44. G. Kanayama, and H.G. Pope Jr. Illicit use of androgens and other hormones: recent advances Curr Opin Endocrinol Diabetes Obes 19 2012 211 219
45. R.S. Tan, and M.C. Scally Anabolic steroid-induced hypogonadism - toward a unified hypothesis of anabolic steroid action Med Hypotheses 72 2009 723 728
46. K. Boregowda, L. Joels, J.W. Stephens, and D.E. Price Persistent primary hypogonadism associated with anabolic steroid abuse Fertil Steril 96 2011 e7 e8
47. G. Kanayama, K.J. Brower, R.I. Wood, J.I. Hudson, and H.G. Pope Jr. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence Am J Psychiatry 166 2009 642 645
48. N.A. Evans Current concepts in anabolic-androgenic steroids Am J Sports Med 32 2004 534 542
49. C. Maravelias, A. Dona, M. Stefanidou, and C. Spiliopoulou Adverse effects of anabolic steroids in athletes. A constant threat Toxicol Lett 158 2005 167 175
50. E. Moretti, G. Collodel, A. La Marca, P. Piomboni, G. Scapigliati, and B. Baccetti Structural sperm and aneuploidies studies in a case of spermatogenesis recovery after the use of androgenic anabolic steroids J Assist Reprod Genet 24 2007 195 198
51. M.R. Graham, B. Davies, F.M. Grace, A. Kicman, and J.S. Baker Anabolic steroid use: patterns of use and detection of doping Sports Med 38 2008 505 525
52. E.D. Kim, L. Crosnoe, N. Bar-Chama, M. Khera, and L.I. Lipshultz The treatment of hypogonadism in men of reproductive age Fertil Steril 99 2013 718 724
53. P.Y. Liu, R.S. Swerdloff, P.D. Christenson, D.J. Handelsman, and C. Wang Hormonal Male Contraception Summit Group. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis Lancet 367 2006 1412 1420
54. J.C. Arce, and M.J. de Souza Exercise and male factor infertility Sports Med 15 1993 146 169
55. M. Boettcher, T. Kosmehl, and T. Braunbeck Low-dose effects and biphasic effect profiles: is trenbolone a genotoxicant? Mutat Res 723 2011 152 157
56. G.B.N. Chainy, S. Samantaray, and L. Samanta Testosterone-induced changes in testicular antioxidant system Andrologia 29 1997 343 349
57. T. Karila, O. Hovatta, and T. Seppälä Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes Int J Sports Med 25 2004 257 263
58. S. Shokri, R.J. Aitken, M. Abdolvahhabi, F. Abolhasani, F.M. Ghasemi, and I. Kashani et al. Exercise and supraphysiological dose of nandrolone decanoate increase apoptosis in spermatogenic cells Basic Clin Pharmacol Toxicol 106 2010 324 330
59. R.A. Harkness, B.H. Kilshaw, and B.M. Hobson Effects of large doses of anabolic steroids Br J Sports Med 9 1975 70 73
60. G.D. Braunstein Aromatase and gynecomastia Endocr Relat Cancer 6 1999 315 324
61. D. LeRoith, R. Sobel, and S.M. Glick The effect of clomiphene citrate on pubertal gynaecomastia Acta Endocrinol (Copenh) 95 1980 177 180
62. P.V. Plourde, H.E. Kulin, and S.J. Santner Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studies Am J Dis Child 137 1983 1080 1082
63. S. Serels, and A. Melman Tamoxifen as treatment for gynecomastia and mastodynia resulting from hormonal deprivation J Urol 159 1998 1309
64. V.R. Staiman, and F.C. Lowe Tamoxifen for flutamide/finasteride-induced gynecomastia Urology 50 1997 929 933
65. A.V. Stepanas, R.B. Burnet, P.E. Harding, and P.H. Wise Clomiphene in the treatment of pubertal-adolescent gynecomastia: a preliminary report J Pediatr 90 1977 651 653
66. C. Bickelman, L. Ferries, and R.P. Eaton Impotence related to anabolic steroid use in a body builder. Response to clomiphene citrate West J Med 162 1995 158 160
67. D.K. Menon Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin Fertil Steril 79 Suppl 3 2003 1659 1661
68. R.S. Tan, and D. Vasudevan Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse Fertil Steril 79 2003 203 205
69. R.L. Weinstein, and R.E. Reitz Pituitary-testicular responsiveness in male hypogonadotropic hypogonadism J Clin Invest 53 1974 408 415
70. D.J. Moskovic, D.J. Katz, A. Akhavan, K. Park, and J.P. Mulhall Clomiphene citrate is safe and effective for long-term management of hypogonadism BJU Int 110 2012 1524 1528
71. D.A. de Luis, R. Aller, L.A. Cuéllar, C. Terroba, and E. Romero [Anabolic steroids and gynecomastia. Review of the literature] An Med Interna 18 2001 489 491
72. G.D. Braunstein Clinical practice. Gynecomastia N Engl J Med 357 2007 1229 1237
73. J. Ferrando, R. Grimalt, M. Alsina, F. Bulla, and E. Manasievska Unilateral gynecomastia induced by treatment with 1 mg of oral finasteride Arch Dermatol 138 2002 543 544
74. L. Green, D.K. Wysowski, and J.L. Fourcroy Gynecomastia and breast cancer during finasteride therapy N Engl J Med 335 1996 823
75. S.C. Lee, and R.J. Ellis Male breast cancer during finasteride therapy J Natl Cancer Inst 96 2004 338 339
76. A.M. Traish, J. Hassani, A.T. Guay, M. Zitzmann, and M.L. Hansen Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients J Sex Med 8 2011 872 884
77. J.K.A. Jameel, P.J. Kneeshaw, V.S.R. Rao, and P.J. Drew Gynaecomastia and the plant product "Tribulis terrestris" Breast 13 2004 428 430
78. A.W.F.T. Toorians, T.F.H. Bovee, J. de Rooy, L.A.A.M. Stolker, and R.L.A.P. Hoogenboom Gynaecomastia linked to the intake of a herbal supplement fortified with diethylstilbestrol Food Addit Contam Part A Chem Anal Control 27 2010 917 925
79. F. Deepinder, and G.D. Braunstein Drug-induced gynecomastia: an evidence-based review Expert Opin Drug Saf 11 2012 779 795
80. G. Dickson Gynecomastia Am Fam Physician 85 2012 716 722
81. S. Hanavadi, D. Banerjee, I.J. Monypenny, and R.E. Mansel The role of tamoxifen in the management of gynaecomastia Breast 15 2006 276 280
82. F. Spano, and W.G. Ryan Tamoxifen for gynecomastia induced by anabolic steroids? N Engl J Med 311 1984 861 862
83. A. Babigian, and R.T. Silverman Management of gynecomastia due to use of anabolic steroids in bodybuilders Plast Reconstr Surg 107 2001 240 242
84. D. Neild Gynaecomastia in bodybuilders Br J Clin Pract 49 1995 172
85. F. Boccardo, A. Rubagotti, M. Battaglia, P. di Tonno, F.P. Selvaggi, and G. Conti et al. Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer J Clin Oncol 23 2005 808 815
86. S.E. Lawrence, K.A. Faught, J. Vethamuthu, and M.L. Lawson Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia J Pediatr 145 2004 71 76
87. L.N. Parker, D.R. Gray, M.K. Lai, and E.R. Levin Treatment of gynecomastia with tamoxifen: a double-blind crossover study Metabolism 35 1986 705 708
88. J. Buvat, K. Ardaens, A. Lemaire, A. Gauthier, J.P. Gasnault, and M. Buvat-Herbaut Increased sperm count in 25 cases of idiopathic normogonadotropic oligospermia following treatment with tamoxifen Fertil Steril 39 1983 700 703
89. L. de la Torre Abril, F. Ramada Benlloch, F. Sánchez Ballester, F. Ordoño Domínguez, J. Ulises Juan Escudero, and P. Navalón Verdejo et al. [Management of male sterility in patients taking anabolic steroids] Arch Esp Urol 58 2005 241 244
90. J.M. Dony, A.G. Smals, R. Rolland, B.C. Fauser, and C.M. Thomas Effect of lower versus higher doses of tamoxifen on pituitary-gonadal function and sperm indices in oligozoospermic men Andrologia 17 1985 369 378
91. E. Tsourdi, A. Kourtis, D. Farmakiotis, I. Katsikis, M. Salmas, and D. Panidis The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia Fertil Steril 91 2009 1427 1430
92. J.D. Veldhuis, and M.L. Dufau Estradiol modulates the pulsatile secretion of biologically active luteinizing hormone in man J Clin Invest 80 1987 631 638
93. A. Vermeulen, and F. Comhaire Hormonal effects of an antiestrogen, tamoxifen, in normal and oligospermic men Fertil Steril 29 1978 320 327
94. J.S. Finkelstein, H. Lee, S.-A.M. Burnett-Bowie, J.C. Pallais, E.W. Yu, and L.F. Borges et al. Gonadal steroids and body composition, strength, and sexual function in men N Engl J Med 369 2013 1011 1022
95. G.R. Dohle, M. Smit, and R.F.A. Weber Androgens and male fertility World J Urol 21 2003 341 345
96. F. Lombardo, P. Sgrò, P. Salacone, B. Gilio, L. Gandini, and F. Dondero et al. Androgens and fertility J Endocrinol Invest 28 2005 51 55
97. C.J. Bagatell, and W.J. Bremner Androgens in men - uses and abuses N Engl J Med 334 1996 707 714
98. E.Y. Ko, K. Siddiqi, R.E. Brannigan, and E.S. Sabanegh Jr. Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association J Urol 187 2012 973 978
99. S. Basaria Androgen abuse in athletes: detection and consequences J Clin Endocrinol Metab 95 2010 1533 1543
100. M.R. Gazvani, W. Buckett, M.J. Luckas, I.A. Aird, L.J. Hipkin, and D.I. Lewis-Jones Conservative management of azoospermia following steroid abuse Hum Reprod 12 1997 1706 1708
101. U.A. Knuth, H. Maniera, and E. Nieschlag Anabolic steroids and semen parameters in bodybuilders Fertil Steril 52 1989 1041 1047
102. P.J. Turek, R.H. Williams, J.H. Gilbaugh 3rd, and L.I. Lipshultz The reversibility of anabolic steroid-induced azoospermia J Urol 153 1995 1628 1630
103. B.H. Grokett, N. Ahmad, and D.W. Warren The effects of an anabolic steroid (oxandrolone) on reproductive development in the male rat Acta Endocrinol (Copenh) 126 1992 173 178
104. T.-C. Hsieh, A.W. Pastuszak, K. Hwang, and L.I. Lipshultz Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy J Urol 189 2013 647 650
105. E. Vicari, A. Mongioì, A.E. Calogero, M.L. Moncada, G. Sidoti, and P. Polosa et al. Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism - long-term follow-up Int J Androl 15 1992 320 329
106. S.-O. Kim, K.H. Ryu, I.S. Hwang, S.I. Jung, K.J. Oh, and K. Park Penile growth in response to human chorionic gonadotropin (hCG) treatment in patients with idiopathic hypogonadotrophic hypogonadism Chonnam Med J 47 2011 39 42
107. F.H. Gardner, D.G. Nathan, S. Piomelli, and J.F. Cummins The erythrocythaemic effects of androgen Br J Haematol 14 1968 611 615
108. L.J. Gooren Androgens and male aging: current evidence of safety and efficacy Asian J Androl 12 2010 136 151
109. K. Stergiopoulos, J.J. Brennan, R. Mathews, J.F. Setaro, and S. Kort Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature Vasc Health Risk Manag 4 2008 1475 1480